Stay up to date on recent news within the bleeding disorders community.
- Medical Advisory #424: Grifols Announces Recall of One Lot of Profilnine
- Genentech Announces the Launch of New Safety Website
- HEMLIBRA® Granted Priority Review by FDA
- HEMLIBRA® Granted Priority Review By FDA
- FDA Approves New Vial Size for Idelvion®
- uniQure Reports Successful Delivery of FIX Gene Therapy Despite Antibodies
- Who are the Stars of the Bleeding Disorders Community?
- Who are the Stars of the Bleeding Disorders Community?
- NHF’s Dawn Rotellini Elected to WFH Board of Directors
- Genentech Announces Positive HEMLIBRA Trial Results
- HFA and NHF Issue Joint Statement Regarding Shire Lawsuit Against Genentech/Roche
- Genentech Provides Statement Regarding Patient Access to Hemlibra
- Fit Factor: Inspiring Fitness Stories to Get You Going in 2018
- PSI Files Lawsuit Against U.S. Department of Health and Human Services
- Alnylam and Sanofi Enter into Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance
